Jeito Capital
Paris, France · Series A → Growth
Their stated focus (public profile)
Jeito Capital is the largest fully independent European fund dedicated to biopharma, with €1.6bn under management. It finances and accelerates cutting-edge medical innovation through a patient-benefit-driven approach, providing significant capital and support from clinical development to market access. The fund focuses on therapeutic areas of high unmet medical need including oncology, autoimmune/inflammatory diseases, ophthalmology, cardiology, neuromuscular, neurodegenerative, cardio-metabolic diseases, obesity, and women's health, primarily backing European biopharma companies.
Stages: Series A → Growth
Sectors: Life sciences, Cardiology
On file: 14 partners on record · 22 companies on record
Website: jeito.life
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.